Published in Rinsho Shinkeigaku on July 01, 1994
Visual evoked potentials in guillain-barré syndrome. J Clin Neurol (2011) 0.90
Anti-GQ1b IgG antibody syndrome: clinical and immunological range. J Neurol Neurosurg Psychiatry (2001) 3.05
Early-onset ataxia with ocular motor apraxia and hypoalbuminemia is caused by mutations in a new HIT superfamily gene. Nat Genet (2001) 2.79
Myoclonus epilepsy associated with ragged-red fibres (mitochondrial abnormalities ): disease entity or a syndrome? Light-and electron-microscopic studies of two cases and review of literature. J Neurol Sci (1980) 2.34
Motoneuron-disease-like disorder after ganglioside therapy. Lancet (1991) 2.30
Hepatitis C virus antibody and hepatitis C virus replication in chronic hepatitis B patients. J Hepatol (1994) 2.23
Clinical features and prognosis of Miller Fisher syndrome. Neurology (2001) 1.83
A patient with overlapping Bickerstaff's brainstem encephalitis, Miller Fisher syndrome and Guillain-Barré syndrome during the clinical course. Eur J Neurol (2002) 1.81
Campylobacter gene polymorphism as a determinant of clinical features of Guillain-Barré syndrome. Neurology (2005) 1.80
Relation between critical illness polyneuropathy and axonal Guillain-Barré syndrome. J Neurol Neurosurg Psychiatry (1999) 1.78
Multifocal motor neuropathy: association of anti-GM1 IgM antibodies with clinical features. Neurology (2010) 1.72
Acute facial diplegia and hyperreflexia: A Guillain-Barré syndrome variant. Neurology (2004) 1.68
Does Campylobacter jejuni infection elicit "demyelinating" Guillain-Barre syndrome? Neurology (2004) 1.67
Early administration of Bifidobacterium breve to preterm infants: randomised controlled trial. Arch Dis Child Fetal Neonatal Ed (1997) 1.58
Bickerstaff's brainstem encephalitis and Fisher syndrome form a continuous spectrum: clinical analysis of 581 cases. J Neurol (2008) 1.57
Fine specificity of anti-GQ1b IgG and clinical features. J Neurol Sci (2001) 1.53
Axonal Guillain-Barré syndrome: relation to anti-ganglioside antibodies and Campylobacter jejuni infection in Japan. Ann Neurol (2000) 1.50
TAL1 and LIM-only proteins synergistically induce retinaldehyde dehydrogenase 2 expression in T-cell acute lymphoblastic leukemia by acting as cofactors for GATA3. Mol Cell Biol (1998) 1.49
Bickerstaff's brainstem encephalitis subsequent to Campylobacter jejuni enteritis. J Neurol Neurosurg Psychiatry (2000) 1.46
Serial electrodiagnostic studies increase the diagnostic yield of axonal Guillain-Barré syndrome. Clin Neurophysiol (2012) 1.42
Complex visual hallucination and mirror sign in posterior cortical atrophy. Acta Psychiatr Scand (2006) 1.38
Antecedent infections in Fisher syndrome: a common pathogenesis of molecular mimicry. Neurology (2005) 1.37
IgG anti-GM1 antibody is associated with reversible conduction failure and axonal degeneration in Guillain-Barré syndrome. Ann Neurol (1998) 1.37
Specific serotype of Campylobacter jejuni associated with Guillain-Barré syndrome. J Infect Dis (1992) 1.37
Identification of a mutation in the arylsulfatase A gene of a patient with adult-type metachromatic leukodystrophy. Am J Hum Genet (1991) 1.35
Hyperreflexia in Guillain-Barré syndrome: relation with acute motor axonal neuropathy and anti-GM1 antibody. J Neurol Neurosurg Psychiatry (1999) 1.33
VP4 protein of porcine rotavirus strain OSU expressed by a baculovirus recombinant induces neutralizing antibodies. Virology (1989) 1.20
Rimmed vacuoles. Acta Neuropathol (1980) 1.16
Serotype of Campylobacter jejuni, HLA, and the Guillain-Barré syndrome. Muscle Nerve (1992) 1.16
Involvement of the zinc-binding capacity of Sendai virus V protein in viral pathogenesis. J Virol (2000) 1.15
Identification of temperature-sensitive dnaD mutants of Staphylococcus aureus that are defective in chromosomal DNA replication. Mol Genet Genomics (2004) 1.13
TS-071 is a novel, potent and selective renal sodium-glucose cotransporter 2 (SGLT2) inhibitor with anti-hyperglycaemic activity. Br J Pharmacol (2011) 1.11
Surgery itself does not trigger Guillain-Barré syndrome. Eur J Neurol (2013) 1.08
Characterization of monoclonal antibodies against human rotavirus hemagglutinin. J Med Virol (1986) 1.08
Gene locus for autosomal recessive distal myopathy with rimmed vacuoles maps to chromosome 9. Ann Neurol (1997) 1.07
Treatment for Fisher syndrome, Bickerstaff's brainstem encephalitis and related disorders. Cochrane Database Syst Rev (2007) 1.07
Transcriptional activity of TAL1 in T cell acute lymphoblastic leukemia (T-ALL) requires RBTN1 or -2 and induces TALLA1, a highly specific tumor marker of T-ALL. J Biol Chem (1997) 1.02
Indicators of rapid clinical recovery in Guillain-Barré syndrome. J Neurol Neurosurg Psychiatry (2001) 1.02
Preserved tendon reflexes in Campylobacter neuropathy. Ann Neurol (1998) 1.01
"Tail sign" associated with microembolic signals. Stroke (1999) 0.98
Rapidly progressive, predominantly motor Guillain-Barré syndrome with anti-GalNAc-GD1a antibodies. Neurology (1999) 0.98
Close association of IgA anti-ganglioside antibodies with antecedent Campylobacter jejuni infection in Guillain-Barré and Fisher's syndromes. J Neuroimmunol (1998) 0.98
Are Campylobacter curvus and Campylobacter upsaliensis antecedent infectious agents in Guillain-Barré and Fisher's syndromes? J Neurol Sci (1999) 0.97
Evidence of duplication and deletion in super short segment 11 of rabbit rotavirus Alabama strain. Virology (1989) 0.97
Adrenoleukodystrophy: a clinical variant presenting as olivopontocerebellar atrophy. J Neurol (1984) 0.96
Patterns and serial changes in electrodiagnostic abnormalities of axonal Guillain-Barré syndrome. Neurology (2005) 0.96
Intra-axonal corpora amylacea in the peripheral nerve seen in a healthy woman. J Neurol Sci (1977) 0.96
Identification of a highly specific surface marker of T-cell acute lymphoblastic leukemia and neuroblastoma as a new member of the transmembrane 4 superfamily. Int J Cancer (1995) 0.96
Distal myopathy: histochemical and ultrastructural studies. Arch Neurol (1982) 0.96
Acute sensory ataxic neuropathy associated with monospecific anti-GD1b IgG antibody. Neurology (2001) 0.95
Usefulness of anti-GQ1b IgG antibody testing in Fisher syndrome compared with cerebrospinal fluid examination. J Neuroimmunol (2004) 0.95
Serologic characteristics of a human rotavirus isolate, AU-1, which has a "long" RNA pattern and subgroup I specificity. J Med Virol (1987) 0.95
Antibodies to GD3, GT3, and O-acetylated species in Guillain-Barré and Fisher's syndromes: their association with cranial nerve dysfunction. J Neurol Sci (1999) 0.94
Ultrastructural studies on the neuromuscular junctions of Becker's muscular dystrophy. Acta Neuropathol (1985) 0.94
Axonal involvement at the common entrapment sites in Guillain-Barré syndrome with IgG anti-GM1 antibody. Muscle Nerve (1999) 0.93
Bickerstaff's brainstem encephalitis associated with IgG anti-GQ1b antibody subsequent to Mycoplasma pneumoniae infection: favorable response to immunoadsorption therapy. J Child Neurol (1997) 0.93
Two patterns of clinical recovery in Guillain-Barré syndrome with IgG anti-GM1 antibody. Neurology (1998) 0.92
Unilateral oculomotor nerve palsy associated with anti-GQ1b IgG antibody. Neurology (2002) 0.92
Anti-GT1a IgG in Guillain-Barré syndrome. J Neurol Neurosurg Psychiatry (2002) 0.92
Acute motor axonal neuropathy after Mycoplasma infection: Evidence of molecular mimicry. Neurology (2004) 0.92
Strong induction of ICAM-1 in human T cells transformed by human T-cell-leukemia virus type 1 and depression of ICAM-1 or LFA-1 in adult T-cell-leukemia-derived cell lines. Int J Cancer (1992) 0.92
Miller Fisher syndrome and Haemophilus influenzae infection. Neurology (2001) 0.91
Familial Guillain-Barré syndrome subsequent to Campylobacter jejuni enteritis. J Pediatr (1995) 0.91
Long-term follow-up of hepatitis B virus and hepatitis C virus replicative levels in chronic hepatitis patients coinfected with both viruses. J Med Virol (1995) 0.91
Unilateral ophthalmoparesis and limb ataxia associated with anti-GQ1b IgG antibody. J Neurol (2000) 0.91
Clinical predictors of mechanical ventilation in Fisher/Guillain-Barré overlap syndrome. J Neurol Neurosurg Psychiatry (2008) 0.91
Antiganglioside antibodies in various episodes in a patient with recurrent Guillain-Barré syndrome. J Neurol Neurosurg Psychiatry (1998) 0.90
Structural polypeptides of the murine coronavirus DVIM. Arch Virol (1986) 0.90
A case of recurrent Guillain-Barré syndrome preceded by different infections. J Neurol (1993) 0.90
Isolated absence of F waves and proximal axonal dysfunction in Guillain-Barré syndrome with antiganglioside antibodies. J Neurol Neurosurg Psychiatry (2000) 0.89
Evaluation of Bifidobacterium breve strain Yakult-fermented soymilk as a probiotic food. Int J Food Microbiol (2003) 0.89
Bickerstaff's brainstem encephalitis associated with cytomegalovirus infection. J Neurol Neurosurg Psychiatry (1995) 0.89
Gadolinium-enhancement of the spinal posterior roots in acute sensory ataxic neuropathy. Neurology (1997) 0.89
Fabry's disease on the mechanism of the peripheral nerve involvement. Acta Neuropathol (1975) 0.88
HCV viraemia and liver injury in symptom-free blood donors. Lancet (1993) 0.87
Antecedent symptoms in Guillain-Barré syndrome: an important indicator for clinical and serological subgroups. Acta Neurol Scand (2001) 0.87
Relationship of bacterial strains to clinical syndromes of Campylobacter-associated neuropathies. Neurology (2006) 0.87
Two cases of influenza with impaired ocular movement. Eur J Paediatr Neurol (2001) 0.86
Nemaline myopathy: histological, histochemical and ultrastructural studies. Acta Neuropathol (1978) 0.86
Bilateral ballism in a patient with overlapping Fisher's and Guillain-Barré syndromes. J Neurol Neurosurg Psychiatry (1999) 0.86
Range of cross reactivity of anti-GM1 IgG antibody in Guillain-Barré syndrome. J Neurol Neurosurg Psychiatry (2001) 0.86
Is IgG anti-GT1a antibody associated with pharyngeal-cervical-brachial weakness or oropharyngeal palsy in Guillain-Barré syndrome? J Neuroimmunol (1998) 0.85
Blood--nerve barrier: effect of ligation of the peripheral nerve. Exp Neurol (1979) 0.85
[Atypical Fisher syndrome with optic nerve involvement]. No To Shinkei (2001) 0.85
Expression of X protein and hepatitis B virus replication in chronic hepatitis. Hepatology (1991) 0.85
Antiganglioside antibody in patients with Guillain-Barré syndrome who show bulbar palsy as an initial symptom. J Neurol Neurosurg Psychiatry (1999) 0.85
Guillain-Barré and Fisher's syndromes subsequent to Campylobacter jejuni enteritis are associated with HLA-B54 and Cw1 independent of anti-ganglioside antibodies. J Neuroimmunol (1998) 0.85
Pain in Miller Fisher syndrome. J Neurol (2000) 0.84
Cranial nerve enhancement on three-dimensional MRI in Miller Fisher syndrome. Neurology (1996) 0.84
Eaton-Lambert syndrome. Ultrastructural study of the motor end-plates. Arch Neurol (1972) 0.84
Motor neuron disease with multi-system involvement presenting as tetraparesis, ophthalmoplegia and sensori-autonomic dysfunction. Acta Neuropathol (1994) 0.84
Oculopharyngeal muscular dystrophy and distal myopathy. Intrafamilial difference in the onset and distribution of muscular involvement. Acta Neurol Scand (1982) 0.84
An autopsy case of mitochondrial encephalomyopathy: biochemical and electron microscopic studies of the brain. J Neurol Sci (1988) 0.84
Strokelike episodes in MERRF. Ann Neurol (1985) 0.83
A novel synbiotic therapy dramatically improved the intestinal function of a pediatric patient with laryngotracheo-esophageal cleft (LTEC) in the intensive care unit. Clin Nutr (2002) 0.83
Immunoadsorption therapy for Fisher syndrome associated with IgG anti-GQ1b antibody. Am J Ophthalmol (1998) 0.83
Involvement of dopamine, N-methyl-D-aspartate and sigma receptor mechanisms in methamphetamine-induced anticipatory activity rhythm in rats. J Pharmacol Exp Ther (1995) 0.83
Immunoglobulin improves a model of acute motor axonal neuropathy by preventing axonal degeneration. Neurology (2004) 0.83
Side effects of combined therapy of methylprednisolone and intravenous immunoglobulin in Guillain-Barré syndrome. Eur Neurol (2005) 0.83